Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal-Reference-Cited by-同舟云学术

Two Years after Molecular Diagnosis of Familial Hypercholesterolemia: Majority on Cholesterol-Lowering Treatment but a Minority Reaches Treatment Goal

Published:2010-02-15 Issue:2 Volume:5 Page:e9220
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Huijgen Roeland,Kindt Iris,Verhoeven Sjoerd B. J.,Sijbrands Eric J. G.,Vissers Maud N.,Kastelein John J. P.,Hutten Barbara A.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference27 articles.

1. The metabolic and molecular bases of inherited disease.;JL Goldstein,2001

2. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states.;J Slack;Lancet,1969

3. Familial hypercholesterolemia: current treatment and advances in management.;R Huijgen;Expert Rev Cardiovasc Ther,2008

4. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study.;J Versmissen;BMJ,2008

5. Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study.;HA Neil;BMJ,2000

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating genomics and precision health knowledge into practice: A guide for nurse practitioners;Journal of the American Association of Nurse Practitioners;2024-09-05

2. LDLR variant classification for improved cardiovascular risk prediction in familial hypercholesterolemia;Atherosclerosis;2024-06

3. Special Patient Populations;Clinical Lipidology;2024

4. Treatment target achievement in patients with familial hypercholesterolemia: A real-world descriptive study;Clinical Biochemistry;2023-10

5. Cost-effectiveness and Return on Investment of a Nationwide Case-Finding Program for Familial Hypercholesterolemia in Children in the Netherlands;JAMA Pediatrics;2023-06-01